Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
24
IHE Quote, Financials, Valuation and Earnings
Last price:
$65.64
Seasonality move
:
1.02%
Day range:
$65.58 - $66.47
52-week range:
$60.60 - $72.94
Dividend yield:
1.73%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
53.2K
Avg. volume:
56.9K
1-year change:
9.84%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingiShares US Pharmaceuticals ETF has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, iShares US Pharmaceuticals ETF has an estimated downside of -- from its current price of $65.71.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $65.71.
Fair Value
-
According to the consensus of 0 analysts, iShares US Pharmaceuticals ETF has -- downside to fair value with a price target of -- per share.
IHE vs. S&P 500
-
Over the past 5 trading days, iShares US Pharmaceuticals ETF has overperformed the S&P 500 by 0.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
iShares US Pharmaceuticals ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
iShares US Pharmaceuticals ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter iShares US Pharmaceuticals ETF reported revenues of --.
Earnings Growth
-
iShares US Pharmaceuticals ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter iShares US Pharmaceuticals ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
IHE
Sector
Market Cap
--
--
Price % of 52-Week High
90.09%
--
Dividend Yield
1.73%
--
Shareholder Yield
--
--
1-Year Price Total Return
9.84%
--
Beta (5-Year)
0.656
--
Dividend yield:
1.73%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$66.43
200-day SMA
Sell
Level
$68.01
Bollinger Bands (100)
Sell
Level
67.96 - 71.5
Chaikin Money Flow
Buy
Level
25.5M
20-day SMA
Sell
Level
$67.85
Relative Strength Index (RSI14)
Sell
Level
32.33
ADX Line
Buy
Level
7.47
Williams %R
Buy
Level
-83.9286
50-day SMA
Sell
Level
$68.89
MACD (12, 26)
Sell
Level
-0.86
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
28.2M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, IHE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IHE average analyst price target in the past 3 months is --.
-
Where Will iShares US Pharmaceuticals ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that iShares US Pharmaceuticals ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About iShares US Pharmaceuticals ETF?
Analysts are divided on their view about iShares US Pharmaceuticals ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iShares US Pharmaceuticals ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is iShares US Pharmaceuticals ETF's Price Target?
The price target for iShares US Pharmaceuticals ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IHE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for iShares US Pharmaceuticals ETF is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IHE?
You can purchase shares of iShares US Pharmaceuticals ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iShares US Pharmaceuticals ETF shares.
-
What Is The iShares US Pharmaceuticals ETF Share Price Today?
iShares US Pharmaceuticals ETF was last trading at $65.64 per share. This represents the most recent stock quote for iShares US Pharmaceuticals ETF. Yesterday, iShares US Pharmaceuticals ETF closed at $65.71 per share.
-
How To Buy iShares US Pharmaceuticals ETF Stock Online?
In order to purchase iShares US Pharmaceuticals ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
